Table 2 Baseline pathological characteristics in IMN patients with and without DM

Ehrenreich-Churg stage

0.578

MN I + II (n, %)

124 (75.6)

30 (71.4)

MN III + IV (n, %)

40 (24.4)

12 (28.6)

Global sclerosis

39 (23.8)

9 (21.4)

0.748

Segmental sclerosis

35 (21.3)

8 (19.4)

0.744

Tubular atrophy (n, %)

0.889

Atrophy area < 25%

157 (95.7)

40 (95.2)

Atrophy area ≥ 25%

7 (4.3)

2 (4.8)

Interstitial ICI (n, %)

143 (87.2)

38 (90.5)

0.561

Interstitial fibrosis (n, %)

54 (32.9)

14 (33.3)

0.960

Renal arteriopathy (n, %)

131 (79.9)

33 (78.6)

0.851

IgG1 (n, %)

133 (81.1)

35 (83.3)

0.739

IgG2 (n, %)

103 (62.8)

26 (61.9)

0.914

IgG3 (n, %)

73 (44.5)

18 (42.9)

0.847

IgG4 (n, %)

155 (94.5)

39 (92.9)

0.683

IgA deposit (n, %)

4 (2.4)

2 (4.8)

0.424

IgM deposit (n, %)

137 (83.5)

34 (81.0)

0.691

C3 deposit (n, %)

158 (96.3)

42 (100)

0.350

C1q deposit (n, %)

5 (3.0)

3 (7.1)

0.220

Positive PLA2R deposit (n, %)

127 (77.4)

35 (83.3)

0.406

Positive THSD7A deposit (n, %)^a

0 (0)

0 (0)

–

Average GBMT (nm)

1440 ± 338

1524 ± 316

0.150